Lixte Biotechnology Holdings Inc (LIXT)
1.85
+0.05
(+2.78%)
USD |
NASDAQ |
Oct 04, 16:00
1.90
+0.05
(+2.70%)
After-Hours: 20:00
Lixte Biotechnology Holdings Shareholders Equity (Annual): 3.995M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 3.995M |
December 31, 2022 | 5.165M |
December 31, 2021 | 4.790M |
December 31, 2020 | 5.012M |
December 31, 2019 | 2.434M |
December 31, 2018 | 4.126M |
December 31, 2017 | 0.995M |
December 31, 2016 | 0.2148M |
December 31, 2015 | 0.3123M |
December 31, 2014 | 0.2659M |
Date | Value |
---|---|
December 31, 2013 | 0.2363M |
December 31, 2012 | 1.492M |
December 31, 2011 | 0.079M |
December 31, 2010 | 1.736M |
December 31, 2009 | 1.301M |
December 31, 2008 | -0.3235M |
December 31, 2007 | 0.3769M |
December 31, 2006 | 0.6266M |
December 31, 2005 | -0.0146M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
2.434M
Minimum
2019
5.165M
Maximum
2022
4.279M
Average
4.790M
Median
2021
Shareholders Equity (Annual) Benchmarks
Soligenix Inc | 2.522M |
Tonix Pharmaceuticals Holding Corp | 105.52M |
Shuttle Pharmaceuticals Holdings Inc | 4.056M |
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -0.1115M |